nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNB1—epithelium—Crohn's disease	0.0461	0.0746	CbGeAlD
Dalfampridine—KCNC3—epithelium—Crohn's disease	0.0447	0.0724	CbGeAlD
Dalfampridine—KCNB1—smooth muscle tissue—Crohn's disease	0.0444	0.0719	CbGeAlD
Dalfampridine—KCNS1—epithelium—Crohn's disease	0.0414	0.067	CbGeAlD
Dalfampridine—KCNG3—lymphoid tissue—Crohn's disease	0.0411	0.0665	CbGeAlD
Dalfampridine—KCNA3—lymphoid tissue—Crohn's disease	0.0335	0.0542	CbGeAlD
Dalfampridine—KCNA3—digestive system—Crohn's disease	0.0331	0.0536	CbGeAlD
Dalfampridine—KCNC1—mammalian vulva—Crohn's disease	0.033	0.0534	CbGeAlD
Dalfampridine—KCNS3—epithelium—Crohn's disease	0.0297	0.0481	CbGeAlD
Dalfampridine—KCNA5—smooth muscle tissue—Crohn's disease	0.0292	0.0473	CbGeAlD
Dalfampridine—KCNS3—skin of body—Crohn's disease	0.0282	0.0457	CbGeAlD
Dalfampridine—KCNS3—mammalian vulva—Crohn's disease	0.0257	0.0417	CbGeAlD
Dalfampridine—KCNA5—digestive system—Crohn's disease	0.0231	0.0373	CbGeAlD
Dalfampridine—KCNQ1—mammalian vulva—Crohn's disease	0.0189	0.0307	CbGeAlD
Dalfampridine—KCNA3—lymph node—Crohn's disease	0.0189	0.0306	CbGeAlD
Dalfampridine—KCNA2—lymph node—Crohn's disease	0.018	0.0291	CbGeAlD
Dalfampridine—Pharyngolaryngeal pain—Mesalazine—Crohn's disease	0.0178	0.0465	CcSEcCtD
Dalfampridine—Laryngeal pain—Mesalazine—Crohn's disease	0.0176	0.0461	CcSEcCtD
Dalfampridine—KCNC4—lymph node—Crohn's disease	0.0172	0.0278	CbGeAlD
Dalfampridine—KCNQ1—digestive system—Crohn's disease	0.0166	0.0269	CbGeAlD
Dalfampridine—KCNQ5—lymph node—Crohn's disease	0.0161	0.026	CbGeAlD
Dalfampridine—KCNA5—lymph node—Crohn's disease	0.0132	0.0213	CbGeAlD
Dalfampridine—KCNS3—lymph node—Crohn's disease	0.0129	0.0209	CbGeAlD
Dalfampridine—Immune system disorder—Mercaptopurine—Crohn's disease	0.01	0.0262	CcSEcCtD
Dalfampridine—KCND3—lymph node—Crohn's disease	0.0098	0.0159	CbGeAlD
Dalfampridine—KCNQ1—lymph node—Crohn's disease	0.00949	0.0154	CbGeAlD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00818	0.0214	CcSEcCtD
Dalfampridine—Nasopharyngitis—Mesalazine—Crohn's disease	0.00779	0.0204	CcSEcCtD
Dalfampridine—Skin disorder—Mercaptopurine—Crohn's disease	0.00767	0.02	CcSEcCtD
Dalfampridine—Infestation—Azathioprine—Crohn's disease	0.00737	0.0193	CcSEcCtD
Dalfampridine—Infestation NOS—Azathioprine—Crohn's disease	0.00737	0.0193	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00681	0.0178	CcSEcCtD
Dalfampridine—Infestation NOS—Mesalazine—Crohn's disease	0.00672	0.0176	CcSEcCtD
Dalfampridine—Infestation—Mesalazine—Crohn's disease	0.00672	0.0176	CcSEcCtD
Dalfampridine—Urinary tract infection—Mesalazine—Crohn's disease	0.00653	0.0171	CcSEcCtD
Dalfampridine—Immune system disorder—Azathioprine—Crohn's disease	0.00598	0.0156	CcSEcCtD
Dalfampridine—Mediastinal disorder—Azathioprine—Crohn's disease	0.00596	0.0156	CcSEcCtD
Dalfampridine—Connective tissue disorder—Mesalazine—Crohn's disease	0.00592	0.0155	CcSEcCtD
Dalfampridine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00581	0.0152	CcSEcCtD
Dalfampridine—Angiopathy—Mesalazine—Crohn's disease	0.00547	0.0143	CcSEcCtD
Dalfampridine—Immune system disorder—Mesalazine—Crohn's disease	0.00545	0.0142	CcSEcCtD
Dalfampridine—Mediastinal disorder—Mesalazine—Crohn's disease	0.00543	0.0142	CcSEcCtD
Dalfampridine—Mental disorder—Mesalazine—Crohn's disease	0.00528	0.0138	CcSEcCtD
Dalfampridine—Back pain—Mesalazine—Crohn's disease	0.00508	0.0133	CcSEcCtD
Dalfampridine—Vomiting—Mercaptopurine—Crohn's disease	0.00502	0.0131	CcSEcCtD
Dalfampridine—Rash—Mercaptopurine—Crohn's disease	0.00498	0.013	CcSEcCtD
Dalfampridine—Dermatitis—Mercaptopurine—Crohn's disease	0.00497	0.013	CcSEcCtD
Dalfampridine—CYP2E1—lymphoid tissue—Crohn's disease	0.00494	0.008	CbGeAlD
Dalfampridine—Tremor—Mesalazine—Crohn's disease	0.00492	0.0129	CcSEcCtD
Dalfampridine—CYP2E1—digestive system—Crohn's disease	0.00488	0.0079	CbGeAlD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00487	0.0127	CcSEcCtD
Dalfampridine—Angioedema—Mesalazine—Crohn's disease	0.0048	0.0125	CcSEcCtD
Dalfampridine—Nausea—Mercaptopurine—Crohn's disease	0.00469	0.0123	CcSEcCtD
Dalfampridine—Infection—Azathioprine—Crohn's disease	0.00467	0.0122	CcSEcCtD
Dalfampridine—Skin disorder—Azathioprine—Crohn's disease	0.00457	0.0119	CcSEcCtD
Dalfampridine—Chest pain—Mesalazine—Crohn's disease	0.00447	0.0117	CcSEcCtD
Dalfampridine—Anxiety—Mesalazine—Crohn's disease	0.00445	0.0116	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00444	0.0116	CcSEcCtD
Dalfampridine—Hypotension—Azathioprine—Crohn's disease	0.00439	0.0115	CcSEcCtD
Dalfampridine—Confusional state—Mesalazine—Crohn's disease	0.00432	0.0113	CcSEcCtD
Dalfampridine—Anaphylactic shock—Mesalazine—Crohn's disease	0.00428	0.0112	CcSEcCtD
Dalfampridine—Infection—Mesalazine—Crohn's disease	0.00426	0.0111	CcSEcCtD
Dalfampridine—Nervous system disorder—Mesalazine—Crohn's disease	0.0042	0.011	CcSEcCtD
Dalfampridine—Skin disorder—Mesalazine—Crohn's disease	0.00416	0.0109	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00406	0.0106	CcSEcCtD
Dalfampridine—Hypotension—Mesalazine—Crohn's disease	0.004	0.0105	CcSEcCtD
Dalfampridine—Feeling abnormal—Azathioprine—Crohn's disease	0.00387	0.0101	CcSEcCtD
Dalfampridine—Insomnia—Mesalazine—Crohn's disease	0.00387	0.0101	CcSEcCtD
Dalfampridine—Paraesthesia—Mesalazine—Crohn's disease	0.00385	0.0101	CcSEcCtD
Dalfampridine—Dyspnoea—Mesalazine—Crohn's disease	0.00382	0.00998	CcSEcCtD
Dalfampridine—Dyspepsia—Mesalazine—Crohn's disease	0.00377	0.00986	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.0037	0.00967	CcSEcCtD
Dalfampridine—Constipation—Mesalazine—Crohn's disease	0.00366	0.00958	CcSEcCtD
Dalfampridine—KCNH2—lymph node—Crohn's disease	0.00362	0.00586	CbGeAlD
Dalfampridine—Feeling abnormal—Mesalazine—Crohn's disease	0.00353	0.00923	CcSEcCtD
Dalfampridine—Hypersensitivity—Azathioprine—Crohn's disease	0.00346	0.00906	CcSEcCtD
Dalfampridine—Urticaria—Mesalazine—Crohn's disease	0.0034	0.0089	CcSEcCtD
Dalfampridine—Hypersensitivity—Mesalazine—Crohn's disease	0.00316	0.00825	CcSEcCtD
Dalfampridine—Connective tissue disorder—Prednisone—Crohn's disease	0.00313	0.0082	CcSEcCtD
Dalfampridine—Dizziness—Azathioprine—Crohn's disease	0.00311	0.00813	CcSEcCtD
Dalfampridine—Asthenia—Mesalazine—Crohn's disease	0.00307	0.00804	CcSEcCtD
Dalfampridine—Vomiting—Azathioprine—Crohn's disease	0.00299	0.00782	CcSEcCtD
Dalfampridine—Rash—Azathioprine—Crohn's disease	0.00296	0.00775	CcSEcCtD
Dalfampridine—Dermatitis—Azathioprine—Crohn's disease	0.00296	0.00774	CcSEcCtD
Dalfampridine—Headache—Azathioprine—Crohn's disease	0.00295	0.0077	CcSEcCtD
Dalfampridine—Angiopathy—Prednisone—Crohn's disease	0.00289	0.00757	CcSEcCtD
Dalfampridine—Immune system disorder—Prednisone—Crohn's disease	0.00288	0.00753	CcSEcCtD
Dalfampridine—Dizziness—Mesalazine—Crohn's disease	0.00283	0.00741	CcSEcCtD
Dalfampridine—Mental disorder—Prednisone—Crohn's disease	0.00279	0.00731	CcSEcCtD
Dalfampridine—Nausea—Azathioprine—Crohn's disease	0.00279	0.0073	CcSEcCtD
Dalfampridine—Vomiting—Mesalazine—Crohn's disease	0.00272	0.00712	CcSEcCtD
Dalfampridine—Rash—Mesalazine—Crohn's disease	0.0027	0.00706	CcSEcCtD
Dalfampridine—Dermatitis—Mesalazine—Crohn's disease	0.0027	0.00705	CcSEcCtD
Dalfampridine—Headache—Mesalazine—Crohn's disease	0.00268	0.00702	CcSEcCtD
Dalfampridine—Nausea—Mesalazine—Crohn's disease	0.00254	0.00665	CcSEcCtD
Dalfampridine—Angioedema—Prednisone—Crohn's disease	0.00254	0.00663	CcSEcCtD
Dalfampridine—Convulsion—Prednisone—Crohn's disease	0.00241	0.00629	CcSEcCtD
Dalfampridine—Anxiety—Prednisone—Crohn's disease	0.00236	0.00616	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00235	0.00614	CcSEcCtD
Dalfampridine—Anaphylactic shock—Prednisone—Crohn's disease	0.00227	0.00593	CcSEcCtD
Dalfampridine—Infection—Prednisone—Crohn's disease	0.00225	0.00589	CcSEcCtD
Dalfampridine—Nervous system disorder—Prednisone—Crohn's disease	0.00222	0.00581	CcSEcCtD
Dalfampridine—Skin disorder—Prednisone—Crohn's disease	0.0022	0.00576	CcSEcCtD
Dalfampridine—Insomnia—Prednisone—Crohn's disease	0.00205	0.00536	CcSEcCtD
Dalfampridine—Paraesthesia—Prednisone—Crohn's disease	0.00203	0.00532	CcSEcCtD
Dalfampridine—Dyspepsia—Prednisone—Crohn's disease	0.00199	0.00522	CcSEcCtD
Dalfampridine—Constipation—Prednisone—Crohn's disease	0.00194	0.00507	CcSEcCtD
Dalfampridine—Feeling abnormal—Prednisone—Crohn's disease	0.00187	0.00488	CcSEcCtD
Dalfampridine—Urticaria—Prednisone—Crohn's disease	0.0018	0.00471	CcSEcCtD
Dalfampridine—Hypersensitivity—Prednisone—Crohn's disease	0.00167	0.00437	CcSEcCtD
Dalfampridine—Asthenia—Prednisone—Crohn's disease	0.00163	0.00425	CcSEcCtD
Dalfampridine—Dizziness—Prednisone—Crohn's disease	0.0015	0.00392	CcSEcCtD
Dalfampridine—Vomiting—Prednisone—Crohn's disease	0.00144	0.00377	CcSEcCtD
Dalfampridine—Rash—Prednisone—Crohn's disease	0.00143	0.00374	CcSEcCtD
Dalfampridine—Dermatitis—Prednisone—Crohn's disease	0.00143	0.00373	CcSEcCtD
Dalfampridine—Headache—Prednisone—Crohn's disease	0.00142	0.00371	CcSEcCtD
Dalfampridine—Nausea—Prednisone—Crohn's disease	0.00135	0.00352	CcSEcCtD
